Attention Investors
Kindly note the Change in PAY IN for BSE A/C No. : 1201250000000691 (CDSL), if you have an NSDL A/C, kindly use INTER DEPOSITORY SLIP. For assistance, please call OR contact: Mr. Dadu, 98339 89807 / 022-6145 1000.    |   Exchanges / Depository: Prevent Unauthorized Transactions in your Trading / Demat account --> Update your Mobile Numbers / email IDs with your Stock Brokers / Depository Participant. Receive alerts on your Registered Mobile / email IDs for trading account transactions and all debit and other important transactions in your demat account directly from Exchange / Depository on the same day ......................Issued in the interest of Investors."     |    KYC : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."     |    ASBA-IPO : "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
 ««+1  ««-1
 
 
Caplin Point Laboratories LtdIndustry : Pharmaceuticals - Indian - Formulations
BSE Code:524742NSE Symbol: CAPLIPOINTP/E(TTM):43.56
ISIN Demat:INE475E01026Div & Yield %:0.3EPS(TTM):46
Book Value(Rs):242.5445604Market Cap ( Cr.):15230.08Face Value(Rs):2
    Change Company 
(Rs In Cr)
 Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
SOURCES OF FUNDS :      
Share Capital 15.2015.1915.1815.1615.1315.13
Reserves Total 1685.731374.961124.73915.49743.54584.78
Equity Share Warrants0.000.000.000.000.000.00
Equity Application Money0.000.000.000.000.000.00
Total Shareholders Funds1700.931390.151139.91930.65758.67599.91
Secured Loans 0.000.000.000.000.000.28
Unsecured Loans 1.660.931.340.621.332.13
Total Debt1.660.931.340.621.332.41
Other Liabilities3.323.131.802.683.493.72
Total Liabilities1705.911394.211143.05933.95763.49606.04
APPLICATION OF FUNDS :      
Gross Block 381.41318.45285.13268.64266.23228.35
Less : Accumulated Depreciation 176.15152.66128.28106.1883.5561.43
Less:Impairment of Assets0.000.000.000.000.000.00
Net Block 205.26165.79156.85162.46182.68166.92
Lease Adjustment 0.000.000.000.000.000.00
Capital Work in Progress20.6427.7542.682.601.363.77
Producing Properties0.000.000.000.000.000.00
Investments 802.44584.15485.15264.70149.18195.77
Current Assets, Loans & Advances      
Inventories 66.2686.2551.5342.8124.8722.37
Sundry Debtors 175.33128.6788.2453.7398.46218.98
Cash and Bank214.71215.78271.38316.08345.4958.27
Loans and Advances 58.0634.4240.37141.0833.2820.89
Total Current Assets514.36465.12451.52553.70502.10320.51
Less : Current Liabilities and Provisions      
Current Liabilities 88.64114.11135.0397.2275.3762.27
Provisions 10.683.9910.961.201.160.87
Total Current Liabilities99.32118.10145.9998.4276.5363.14
Net Current Assets415.04347.02305.53455.28425.57257.37
Miscellaneous Expenses not written off 0.000.000.000.000.000.00
Deferred Tax Assets0.000.000.000.000.000.00
Deferred Tax Liability9.2510.0014.1421.7920.9722.14
Net Deferred Tax-9.25-10.00-14.14-21.79-20.97-22.14
Other Assets271.78279.50166.9870.7025.674.36
Total Assets1705.911394.211143.05933.95763.49606.06
Contingent Liabilities0.640.640.640.711.021.28